BMJ  2007;334:1025 (19 May), doi:10.1136/bmj.39212.645486.DB

News

Consumers fight to halt move towards direct to consumer advertising in Europe

Byron Bay

The first 150 words of the full text of this article appear below.

An international alliance of consumer and other groups has attacked the European Commission, accusing it of supporting the drug industry's push for direct to consumer advertising in Europe.

US-style advertising of prescription drugs aimed directly at consumers is currently prohibited in Europe, and attempts to overturn the ban were firmly rejected by the European parliament in 2002 (BMJ 2002;325:990 doi: 10.1136/bmj.325.7371.990/a).

However, the drug industry and elements within the European Commission are pushing to change the rules so that drug companies can provide more information to patients across Europe, a move that critics argue is an underhand way of introducing advertising.

Taking a position in support of loosening the rules, a European Commission draft report that is currently out for public discussion states, "The focus should be on the availability and quality of information, and not its source," and it says that "the pharmaceutical industry has the potential . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

The return of the spoof

Bob Burton
BMJ 2008 336: 589. [Extract] [Full Text] [PDF]

Industry funded patient information and the slippery slope to New Zealand

Les Toop and Dee Mangin
BMJ 2007 335: 694-695. [Extract] [Full Text] [PDF]

Should patient groups accept money from drug companies? No

Barbara Mintzes
BMJ 2007 334: 935. [Extract] [Full Text] [PDF]

MEPs reject US-style direct advertising of drugs

Rory Watson
BMJ 2002 325: 990. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Toop, L., Mangin, D. (2007). Industry funded patient information and the slippery slope to New Zealand. BMJ 335: 694-695 [Full text]